I
Intervacc AB
STO:IVACC
Intervacc AB
STO:IVACC
Price:
0.828
SEK
2.86%
Market Closed
Market Cap:
kr282.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Intervacc AB
STO:IVACC
|
SE |
|
H
|
Huazhang Technology Holding Ltd
HKEX:1673
|
CN |
|
Unimicron Technology Corp
TWSE:3037
|
TW |
|
CSI Properties Ltd
HKEX:497
|
HK |
|
F
|
Fujian Raynen Technology Co Ltd
SSE:603933
|
CN |
|
W
|
World Fuel Services Corp
F:WFK
|
US |
|
A
|
Aurora Solar Technologies Inc
F:A82
|
CA |
|
N
|
Nova Wellness Group Bhd
KLSE:NOVAMSC
|
MY |
|
Delivery Hero SE
LSE:0RTC
|
DE |
|
Gresham Technologies PLC
LSE:GHT
|
UK |
|
B
|
Baolingbao Biology Co Ltd
SZSE:002286
|
CN |
Multiples-Based Value
The Multiples-Based Value for Intervacc AB (IVACC) under the Base Case is hidden SEK. Compared with the current market price of 0.828 SEK, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IVACC Multiples-Based Value
LOCKED
Multiples Across Competitors
IVACC Competitors Multiples
Intervacc AB Competitors
Intervacc AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
I
|
Intervacc AB
STO:IVACC
|
282.2m SEK | 14 | -3.5 | -1.5 | -1.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.3 | 25.1 | 14.5 | 14.5 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.8 | 13 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
